From Step Therapy and Prior Authorization to the harmful impacts of misguided policies such as the Inflation Reduction Act, Most-favored Nation type drug pricing proposals, and the 340B program, patients are increasingly facing barriers accessing the treatments they need. Come join an amazing line-up of patient advocacy leaders to hear about the latest data and […]
Metabolic Dysfunction-Associated Steatotic Liver Disease | MASLD 2026 September 14-15, 2026 | Online Join our 2-days virtual MASLD conference featuring global experts and cutting-edge, content-rich research presentations. Welcome again to the MASLD Virtual Conference! […]
MASLD/NAFLD & Metabolic Liver Disease MASLD/NAFLD & Metabolic Liver Disease encompasses a spectrum of liver disorders driven primarily by metabolic dysfunction, including obesity, insulin resistance, type 2 diabetes mellitus, dyslipidemia, and […]
The Advanced Advocacy Academy (A3) was created to close a critical gap in the liver community: patients and caregivers needed the skills, knowledge, and confidence to advocate effectively—and to help […]
Join us for the 21st Annual Cardiometabolic Health Congress (CMHC), building on over two decades of leadership in cardiometabolic health education. From October 15-17, 2026, with a pre-conference on October […]
